ARTICLE | Distillery Therapeutics
CDC42BPA inhibition for high-grade serous ovarian carcinoma
April 2, 2020 7:25 PM UTC
INDICATION: Ovarian cancer...
BCIQ Company Profiles
BCIQ Target Profiles
INDICATION: Ovarian cancer...
BCIQ Company Profiles
BCIQ Target Profiles
BCIQ Company Profiles
BCIQ Target Profiles